ANSTO (Australian Nuclear Science and Technology Organisation)
ANSTO runs the OPAL research reactor near Sydney and a molybdenum-99 plant that supplies Australia's nuclear medicine and exports, and produces lutetium-177 for radioligand therapy.
Overview
The Australian Nuclear Science and Technology Organisation operates the OPAL reactor at Lucas Heights, commissioned in 2007, and the ANSTO Nuclear Medicine molybdenum-99 processing plant opened in 2019 to serve domestic technetium generators and export. It also produces non-carrier-added lutetium-177 and other isotopes and runs a national radiopharmaceutical distribution operation. Outages at the processing plant in its first years produced domestic shortages and imports from other processors.
Similar pages
not linked directly; found by shared links- CompanyNTP Radioisotopes
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag manufacturing-wave.
- CompanyNordion (Sotera Health)
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag manufacturing-wave.
- CompanyIRE (Institut national des Radioéléments)
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag manufacturing-wave.
- CompanySHINE Technologies
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
- CompanyIsotopia Molecular Imaging
Shares Research reactors for medical isotopes (Mo-99, Lu-177, I-131), Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Lutetium-177 and the tag manufacturing-wave.
- CompanyNusano
Shares Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225) and the tag manufacturing-wave.
- TechnologyActinium-225 supply: thorium stocks, accelerators and radium targets
Shares Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Research reactors for medical isotopes (Mo-99, Lu-177, I-131), Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225) and the tag manufacturing-wave.
- TechnologyRadiopharmaceutical GMP and releasing a drug that decays
Shares Radiopharmacy and cyclotron networks, Research reactors for medical isotopes (Mo-99, Lu-177, I-131), Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Lutetium-177 and the tag manufacturing-wave.